4
Changes in Ownership
Altimmune, Inc. Filed Acc 0000899243-21-004757
Chief Medical Officer acquired 968 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Matthew Scott Chief Medical Officer | 2021-01-31 | Grant or award | +968 | $12.14 | $11,752 | 5,037 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Harris Matthew Scott Chief Medical Officer | 2021-02-01 | Grant or award · Stock Options (option to buy) | +90,000 | 90,000 | D: show line 2 in the form | |||||
| Harris Matthew Scott Chief Medical Officer | 2021-02-01 | Grant or award · Restricted Stock Units | +24,664 | 24,664 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…